Michele Balma

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.

Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 22, 2025

Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT.

Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 08, 2024

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs).

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs).

Journal: Life (Basel, Switzerland)

Published: June 08, 2023

[11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver.

[11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver.

Journal: Nuclear medicine and molecular imaging

Published: June 07, 2023

Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.

Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: April 25, 2023

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.

Journal: Cancers

Published: January 06, 2023

18F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data.

18F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data.

Journal: Endocrine

Published: August 16, 2022

The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years.

The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years.

Journal: Current medical imaging

Published: April 30, 2022

Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.

Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.

Journal: Frontiers in medicine

Published: February 22, 2022

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.

Journal: European radiology experimental

Published: January 18, 2022

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

Journal: Journal of neurology

Published: February 27, 2019

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

Journal: Leukemia

Published: August 07, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026